Please wait while we are processing your request...
Loading .. Loading ..

Cancer Immunotherapy: Antibody Therapy

ID : 44
Available in these categories : Patent Landscape Reports

No rating received yet. [[ productDetailsCtrl.itemRating.totalVotes ]] vote(s) - You have rated [[ productDetailsCtrl.itemRating.selfRating ]] Show Rating & Reviews

Base Price
[[ productOption.optionName ]] + [[productOption.addon_price_format]] -

Price : Price :

Out of Stock
Discount / pricing conflicts, please contact store owner.

Product Description

Cancer Immunotherapy is growing into an increased area of focus for research considering its ability to overcome the drawbacks of conventional radiation therapy. Antibody-based therapy predominates cancer immunotherapy. iRunway’s research found that 52% of patents in this space was related to cell surface antigen binding antibodies. Genentech, Bristol-Myers Squibb, Roche, University of California and University of Texas are among the leading patentees in this space. Read more!

Related Products